Biomarkers Consortium – Bone Quality Project
The Problem Patients with osteoporosis, other bone diseases or increased risk for bone fractures have diminished bone strength and quality,...Biomarkers Consortium Cancer Steering Committee Immuno-Oncology Working Group
The Biomarkers Consortium (BC) is issuing a Request For Proposals (RFP) for novel biomarker development to support the mission of the BC Can...Biomarkers Consortium – Sarcopenia 2
The FNIH Biomarkers Consortium Sarcopenia 2 project, Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability, r...Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density (SV2A PET Project)
The Problem Although researchers have established biomarkers to diagnose Alzheimer’s disease, no biomarker can track cognitive decline ...Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML)
The Problem Detection of measurable residual disease (MRD) is a strong predictor of relapse in acute and chronic leukemia, but its integrat...Biomarkers Consortium – CSC Scientific Symposium
The Problem cancer research is a large and diverse field, making it difficult to coordinate efforts across its many subfields, which are fo...Biomarkers Consortium – ctDNA Quality Control Materials Project
The Problem Tumor DNA circulating in bodily fluids offers researchers a valuable tool to study, and thus to treat, cancer. Yet the wide var...Diseases
Learn more about the diseases we fight
Partner With Us
Work with the FNIH to accelerate medical breakthroughs for patients